Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover bioequivalence study of 200 mg voriconazole tablets in healthy Thai volunteers under fasting
TCTR20180104003Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of voriconazole in mycoses (2 arms), sponsored by International Bio Service. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
voriconazole
03
Conditions
mycoses
Beyond the preview
Go deeper on TCTR20180104003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180104003.